Pharmacists Reaching Out in Diabetes: Optimizing Insulin Therapy Through Patient Engagement and Management
This Continuing Education activity is supported by an educational grant from Novo Nordisk.
This activity is supported by an educational grant from Novo Nordisk.
Faculty
Jessica L. Kerr, PharmD, CDE
Associate Professor
Assistant Chair, Department of Pharmacy Practice
Southern Illinois University Edwardsville School of Pharmacy
Edwardsville, Illinois
Editorial Support
Jill Allen, PharmD
Drug Information Consultant
Pin Oak Associates
Salt Lake City, Utah
Educational Objectives
After completing this continuing education program, the participant will be able to:
- Examine the use of insulin, including pharmacokinetic parameters to reach glycemic control in patients with type 2 diabetes mellitus (T2DM).
- Identify potential patient barriers and recommended solutions to initiating insulin therapy to optimize A1C goals.
- Explore the role of new long-acting basal insulins in patients with T2DM and evaluate risk of hypoglycemia associated with each.
- Analyze the role of the pharmacist in educating patients about proper insulin administration technique and self-monitoring.
- Illustrate an educational strategy that includes a demonstration of proper administration technique to patients and support them with initiating insulin when appropriate.
Target audience: P
harmacists
Type of activity: Application
Release date: April 12, 2016
Expiration date: April 12, 2017
Estimated time to complete activity: 2.0 hours
Fee: Free
Pharmacy Times Continuing Education is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 2.0 contact hours (0.2 CEUs) under the ACPE universal activity number 0290-0000-16-054-H01-P. The activity is available for CE credit through March 7, 2018.
